Journals / Türkiye Parazitoloji Dergisi / 2013 / Cilt: 37 - Sayı: 2

Strongyloides stercoralis hyperinfection syndrome in a patient with behçet's disease

Behçet hastasında strongyloides stercoralis hiperenfeksiyon sendromu

Pages
139–142
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we report a case of Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet’s Disease on immunosuppressive treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Strongyloides stercoralis is endemic in the tropical and subtropical areas of the world.
📊
Key Findings & Data:It is a soil-transmitted intestinal nematode affecting anywhere from 30 to 100 million people worldwide.
💡
Conclusion & Impact:Herein, we report a case of Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet’s Disease on immunosuppressive treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Strongyloides stercoralis is endemic in the tropical and subtropical areas of the world. It is a soil-transmitted intestinal nematode affecting anywhere from 30 to 100 million people worldwide. Strongyloides stercoralis is capable of causing autoinfection, which increases larval migration and proliferation in the host. This condition may lead to hyperinfection syndrome which has the potential to cause serious life- threatening complications, especially in immunosuppressed patients. Thus, Strongyloides stercoralis hyperinfection syndrome should be suspected if there are clinical clues including gastrointestinal tract symptoms (abdominal pain, nausea, vomiting, diarrhoea), respiratory tract symptoms (cough, dyspnoea, wheezing, haemoptysis), skin symptoms (pruritus, erythema) and peripheral eosinophilia in a patient with underlying risk factors. Herein, we report a case of Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet’s Disease on immunosuppressive treatment.

Özet

Strongyloides stercoralis dünyada 30-100 milyon insanı etkileyen çoğunlukla tropikal ve subtropikal bölgelerde endemik olan, topraktan bulaşan intestinal bir nematoddur. Strongyloides stercoralis otoenfeksiyon ile artmış larval proliferasyon ve migrasyona neden olarak özellikle immün yetmezliği olan ya da immünsüpresif tedavi alan hastalarda yaşamı tehdit eden hiperenfeksiyon sendromu’na neden olabilmektedir. Bu nedenle risk grubundaki bu hastalarda; periferal eozinofili, solunum semptomları (öksürük, hırıltı, nefes darlığı, hemoptizi), gastrointestinal (GİS) semptomlar (abdominal ağrı, bulantı, kusma, diyare) ve cilt semptomları (kaşıntı, eritem) varsa gecikmiş tanıdaki mortalite yüksekliği nedeniyle mutlaka Strongyloides stercoralis hiperenfeksiyon sendromu akla getirilmelidir. Burada Behçet hasta

🔖

Cite This Article

BOYVAT, A., AKYOL, A., ÇAĞLAR, B., ALKIZ, G., AKAY, B. N., YILMAZ, İ. (2022). Strongyloides stercoralis hyperinfection syndrome in a patient with behçet's disease. Türkiye Parazitoloji Dergisi, Cilt: 37 - Sayı: 2, 139–142. https://ajindex.com/articles/630341

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989
  2. [CrossRef] 2. Mokhlesi B, Shulzhenko O, Garimella PS, Kuma L, Monti C. Pulmonary Strongyloidiasis: The Varied Clinical Presentations. Clin Pulm Med 2004
  3. [CrossRef] 3. Tamer GS, Dündar D. Case report: strongyloidiosis with chronic abdominal pain. Turkiye Parazitol Derg 2008
  4. KeiserPB,NutmanTB.StrongyloidesstercoralisintheImmunocompromised Population. Clin Microbiol Rev 2004
  5. [CrossRef] 5. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 1993
  6. Sharma OP. Diagnosing pulmonary infiltration with eosinophilia syndrome. J Respir Dis 2002
  7. Dunlap NE, Shin MS, Polt SS, Ho KJ. Strongyloidiasis manifested as asthma. South Med J 1984
  8. [CrossRef] 8. Turhan V, Coban M, Oncül O, Cavuşlu S. Strongyloidiosis and Loeffler’s syndrome detected in a patient who used a short term steroid treatment. Turkiye Parazitol Derg 2008
  9. Berk SL, Verghese A, Alvarez S, Hall K, Smith B. Clinical and epidemiologic features of strongyloidiasis: a prospective study in rural Tennessee. Arch Intern Med 1987
  10. [CrossRef] 10. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection Ann Pharmacother 2007
  11. [CrossRef] 11. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis 2010
  12. [CrossRef] 12. Herbert DR, Lee JJ, Lee NA, Nolan TJ, Schad GA, Abraham D. Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol 2000
  13. Upadhyay D, Corbridge T, Jain M, Shah R. Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Am J Med 2001
  14. [CrossRef]. 14. Weller IV, Copland P, Gabriel R. Strongyloides stercoralis infection in renal transplant recipients. Br Med J (Clin Res Ed) 1981
  15. [CrossRef] 15. Toma H, Sato Y, Shiroma Y, Kobayashi Shimakukuro I, Takara M. Comparative studies on the efficacy of three antihelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian Trop Med Public Health 2000
  16. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS, et al. A comparative trial of a single dose ivermectin versus three days of albendazole for treatment